CVRX vs. TELA, NPCE, SMTI, XAIR, PAVM, PLSE, OFIX, SIBN, BVS, and IRMD
Should you be buying CVRx stock or one of its competitors? The main competitors of CVRx include TELA Bio (TELA), NeuroPace (NPCE), Sanara MedTech (SMTI), Beyond Air (XAIR), PAVmed (PAVM), Pulse Biosciences (PLSE), Orthofix Medical (OFIX), SI-BONE (SIBN), Bioventus (BVS), and Iradimed (IRMD). These companies are all part of the "medical" sector.
CVRx (NASDAQ:CVRX) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, community ranking, institutional ownership and earnings.
CVRx has higher earnings, but lower revenue than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.
CVRx has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.
In the previous week, CVRx had 4 more articles in the media than TELA Bio. MarketBeat recorded 7 mentions for CVRx and 3 mentions for TELA Bio. TELA Bio's average media sentiment score of 1.37 beat CVRx's score of 0.78 indicating that TELA Bio is being referred to more favorably in the news media.
CVRx presently has a consensus target price of $16.60, indicating a potential upside of 124.93%. TELA Bio has a consensus target price of $13.00, indicating a potential upside of 126.48%. Given TELA Bio's stronger consensus rating and higher possible upside, analysts clearly believe TELA Bio is more favorable than CVRx.
TELA Bio has a net margin of -63.82% compared to CVRx's net margin of -123.58%. CVRx's return on equity of -66.05% beat TELA Bio's return on equity.
TELA Bio received 36 more outperform votes than CVRx when rated by MarketBeat users. Likewise, 72.22% of users gave TELA Bio an outperform vote while only 57.14% of users gave CVRx an outperform vote.
75.3% of CVRx shares are owned by institutional investors. Comparatively, 94.4% of TELA Bio shares are owned by institutional investors. 18.9% of CVRx shares are owned by insiders. Comparatively, 6.0% of TELA Bio shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
CVRx and TELA Bio tied by winning 9 of the 18 factors compared between the two stocks.
Get CVRx News Delivered to You Automatically
Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
